McKesson Medical-Surgical Inc. has recalled five cartons of Hylenex recombinant (hyaluronidase) injection because the product was exposed to temperatures outside of required storage limits. This recall affects the 150 USP units/mL strength, which is packaged in cartons containing four 1 mL single-dose vials. Consumers and healthcare providers should check for specific serial numbers listed in the recall to determine if their medication is affected. If you have any health concerns, please consult a healthcare professional.
The medication was subjected to a temperature excursion, which means it was stored or shipped at temperatures that could potentially compromise the product's effectiveness or stability.
Professional/Clinical return coordination
Manufactured for Halozyme, Inc. and distributed by Antares Pharma, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.